MAI Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $214K | Sell |
24,177
-1,846
| -7% | -$16.3K | ﹤0.01% | 1097 |
|
|
2025
Q1 | $204K | Sell |
26,023
-74,567
| -74% | -$584K | ﹤0.01% | 1065 |
|
|
2024
Q4 | $1.06M | Sell |
100,590
-6,943
| -6% | -$73K | 0.01% | 598 |
|
|
2024
Q3 | $1.41M | Buy |
107,533
+1,031
| +1% | +$13.5K | 0.01% | 455 |
|
|
2024
Q2 | $1.5M | Sell |
106,502
-5,103
| -5% | -$71.7K | 0.01% | 469 |
|
|
2024
Q1 | $1.89M | Buy |
111,605
+4,525
| +4% | +$76.4K | 0.02% | 405 |
|
|
2023
Q4 | $1.51M | Buy |
107,080
+61,857
| +137% | +$873K | 0.02% | 370 |
|
|
2023
Q3 | $466K | Sell |
45,223
-6,047
| -12% | -$62.3K | 0.01% | 648 |
|
|
2023
Q2 | $845K | Buy |
+51,270
| New | +$845K | 0.01% | 458 |
|